
The Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Learn more about our Health Equity work.
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
The op-ed unfairly and dangerously diminishes the value of cancer screening in reducing health disparities. As the writers acknowledge, numerous, complex factors contribute to poorer outcomes for Black patients than…
In the latest episode of Medtech POV, Nancy Brown, Chief Executive Officer of the American Heart Association, joins host Scott Whitaker to talk about her journey to leading one of…
This February, AdvaMed® is working with member companies and our global partners to raise awareness and highlight the ways medical technology helps those living with cardiovascular disease live healthier, happier…
MIDI describes recent advancements their team engineered in the biopharma fabrication space.
Heart attack symptoms in women can be different than in men and less well-known as heart attack-related. Women need their heart disease recognized and treated on equal footing with men.
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel® companies, 2022 was a…
October is Breast Cancer Awareness Month and a good time to remember the importance of diagnostic screenings in saving lives.
AdvaMed® submitted a letter to CMS’s RFI on Medicare regarding ways to strengthen the Medicare Advantage program to align with the Vision for Medicare and CMS’ Strategic Pillars.
Mike Mussallem, Chairman and CEO of Edwards Lifesciences, joined AdvaMed®’s Scott Whitaker on the Medtech POV podcast to talk about policy opportunities that could improve the process of getting life-saving medical technologies…